Cite
Emicizumab prophylaxis in infants with severe haemophilia A without inhibitors: Illustrative real‐world cases to support shared decision‐making.
MLA
Mason, Jane A., and Guy Young. “Emicizumab Prophylaxis in Infants with Severe Haemophilia A without Inhibitors: Illustrative Real‐world Cases to Support Shared Decision‐making.” Haemophilia, vol. 27, no. 5, Sept. 2021, pp. 724–29. EBSCOhost, https://doi.org/10.1111/hae.14353.
APA
Mason, J. A., & Young, G. (2021). Emicizumab prophylaxis in infants with severe haemophilia A without inhibitors: Illustrative real‐world cases to support shared decision‐making. Haemophilia, 27(5), 724–729. https://doi.org/10.1111/hae.14353
Chicago
Mason, Jane A., and Guy Young. 2021. “Emicizumab Prophylaxis in Infants with Severe Haemophilia A without Inhibitors: Illustrative Real‐world Cases to Support Shared Decision‐making.” Haemophilia 27 (5): 724–29. doi:10.1111/hae.14353.